- Home
- NBXG vs CDNA Comparison
NBXG vs CDNA Comparison
Compare NBXG & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBXG
- CDNA
- Stock Information
- Founded
- NBXG 2021
- CDNA 1998
- Country
- NBXG United States
- CDNA United States
- Employees
- NBXG N/A
- CDNA N/A
- Industry
- NBXG Trusts Except Educational Religious and Charitable
- CDNA Medical Specialities
- Sector
- NBXG Finance
- CDNA Health Care
- Exchange
- NBXG Nasdaq
- CDNA Nasdaq
- Market Cap
- NBXG 900.2M
- CDNA 1.0B
- IPO Year
- NBXG N/A
- CDNA 2014
- Fundamental
- Price
- NBXG $12.60
- CDNA $15.36
- Analyst Decision
- NBXG
- CDNA Buy
- Analyst Count
- NBXG 0
- CDNA 7
- Target Price
- NBXG N/A
- CDNA $30.33
- AVG Volume (30 Days)
- NBXG 243.7K
- CDNA 1.1M
- Earning Date
- NBXG 01-01-0001
- CDNA 04-30-2025
- Dividend Yield
- NBXG 10.25%
- CDNA N/A
- EPS Growth
- NBXG N/A
- CDNA N/A
- EPS
- NBXG N/A
- CDNA 1.07
- Revenue
- NBXG N/A
- CDNA $346,421,000.00
- Revenue This Year
- NBXG N/A
- CDNA $13.28
- Revenue Next Year
- NBXG N/A
- CDNA $15.13
- P/E Ratio
- NBXG N/A
- CDNA $14.29
- Revenue Growth
- NBXG N/A
- CDNA 25.92
- 52 Week Low
- NBXG $9.31
- CDNA $7.42
- 52 Week High
- NBXG $12.23
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- NBXG 59.71
- CDNA 38.73
- Support Level
- NBXG $12.38
- CDNA $14.09
- Resistance Level
- NBXG $12.77
- CDNA $18.71
- Average True Range (ATR)
- NBXG 0.23
- CDNA 1.03
- MACD
- NBXG 0.11
- CDNA -0.18
- Stochastic Oscillator
- NBXG 88.72
- CDNA 23.48
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.